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High-fiber diets are associated with improved lipid profiles. However, pre- and postmenopausal women respond
differently to fiber intake, suggesting that endogenous estradiol mediates the effect. The authors’ objective was to
determine the direct effect of fiber intake on lipoprotein cholesterol levels independent of estradiol among pre-
menopausal women. The BioCycle Study, a prospective cohort study conducted at the State University of New
York at Buffalo from 2005 to 2007, followed 259 healthy women for up to 2 complete menstrual cycles. Serum
lipoprotein and hormone levels were measured at 16 visits timed using fertility monitors. Fiber intake was assessed
by 8 24-hour recalls. Marginal structural models with inverse probability weights for both lipoprotein and estradiol
levels were used to estimate controlled direct effects of the highest category of fiber intake (22 g/day vs.<22 g/day)
while accounting for age, body mass index, total energy, vitamin E intake, physical activity, luteinizing hormone,
follicle-stimulating hormone, and progesterone. Reductions were observed in total and low density lipoprotein cho-
lesterol in women with higher fiber intakes. Direct effects were greater than total effects. These analyses suggested
that estradiol mediates at least part of the association between fiber and cholesterol among premenopausal women.
More research is needed to elucidate the biologic mechanisms driving these associations.
cholesterol; dietary fiber; estradiol; lipoproteins; menstrual cycle
Abbreviations: BMI, body mass index; FSH, follicle-stimulating hormone; HDL, high density lipoprotein; LDL, low density lipopro-
tein; LH, luteinizing hormone; MSM, marginal structural model.
Editor’s note: An invited commentary on this article ap-
pears on page 157, and the authors’ response appears on
page 160.
High-fiber diets (generally >25 g/day for women) are
recommended because of their many associated health ben-
efits (1, 2). In particular, evidence from randomized con-
trolled trials, observational studies, and animal models
demonstrates that dietary fiber lowers levels of total choles-
terol and low density lipoprotein (LDL) cholesterol (1–5),
which are common risk factors for cardiovascular disease
(1–3, 6, 7). Overall decreases in total cholesterol are usually
attributed to a reduction in LDL cholesterol, since high
density lipoprotein (HDL) cholesterol and triglycerides
have not shown similar effects.
The mechanisms involved in the relation of reduced serum
cholesterol levels to increased fiber intake remain inconclu-
sive, though animal models have provided some insight. The
major mechanism is thought to work through bile acid me-
tabolism (8). However, increased fiber intake does not always
lead to an increased fecal output of bile acids, suggesting that
the reduction in cholesterol may work through another mech-
anism (9, 10). Alternatively, dietary fiber may alter serum sex
hormone concentrations, which could affect lipid metabolism
(9). In fact, high fiber intake in women has been associated
with lower levels of estradiol (11–19). There is also evidence
that pre- and postmenopausal women respond differently to
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fiber intake (20, 21), since premenopausal women have been
found to have smaller reductions in lipoprotein cholesterol
levels in response to fiber intake than postmenopausal
women (20).
We hypothesized that estradiol could mediate fiber’s ef-
fect on lipoprotein cholesterol in premenopausal women. To
date, there has been little research on how much of the
observed effect of fiber on lipoprotein cholesterol levels is
direct and not mediated by estradiol. Therefore, our objec-
tive in this study was to evaluate the effect of dietary fiber
intake on lipoprotein cholesterol levels independent of es-
tradiol among healthy, regularly menstruating women.
Because leading dietary and public health associations con-
tinue to endorse high-fiber diets, a better understanding of
the direct and indirect effects of fiber intake on lipoprotein
cholesterol levels is essential. This knowledge could provide
further insight regarding possible mechanisms, as well as
valuable knowledge for interpreting studies of fiber intake
among women of reproductive age.
MATERIALS AND METHODS
Study sample
The BioCycle Study was a prospective cohort study of
259 women recruited from healthy premenopausal volun-
teers aged 18–44 years during 2005–2007 from western
New York State to study the effects of reproductive hor-
mones on oxidative stress (22). Nine women were followed
for 1 menstrual cycle as part of a pilot study, and an addi-
tional 250 women were recruited and followed for 2 com-
plete cycles (23). Exclusion criteria included pregnancy in
the last 6 months; current use of oral contraceptives, other
medications (including lipid-lowering drugs), and/or aspi-
rin; and diagnosis of certain chronic conditions. Women
with a self-reported body mass index (BMI; weight (kg)/
height (m)2) less than 18 or greater than 35 at screening
were excluded, as were women planning to restrict their diet
for weight loss or medical reasons. Full details on inclusion
and exclusion criteria have been reported elsewhere (23).
The Health Sciences Institutional Review Board of the State
University of New York at Buffalo approved the study, and
all participants provided written informed consent.
Data collection
The study involved 5–8 clinic visits per menstrual cycle
(94% of all women completed at least 7 visits per cycle) for
up to 2 cycles, with visits timed using fertility monitors
(Clearblue Easy Fertility Monitor; Inverness Medical,
Waltham, Massachusetts) so that biospecimen collection oc-
curred during specific phases of the menstrual cycle (24).
Visits corresponded to biologically relevant windows, includ-
ing menstruation, the middle and late follicular phase, lutei-
nizing hormone (LH) and follicle-stimulating hormone (FSH)
surges, ovulation, and the early, middle, and late luteal phase.
Dietary assessment
Dietary intake was assessed using the 24-hour dietary
recall method (25–27). Recalls were conducted 4 times
per menstrual cycle, for a total of up to 8 recalls, by trained
and certified research staff using Nutrition Data System for
Research software, version 2005 (Nutrition Coordinating
Center, University of Minnesota, Minneapolis, Minnesota).
This program computed the nutrients (i.e., total energy, vi-
tamin E) and nonnutrients (i.e., dietary fiber) consumed for
each day of intake. All women completed at least 2 recalls
per cycle, and 87% completed 4 recalls per cycle.
Hormone assessment
Levels of estradiol, progesterone, LH, and FSH were
measured in fasting serum samples collected at each visit
(28). Estradiol was measured by radioimmunoassay. Pro-
gesterone, LH, and FSH were measured using a solid-phase
competitive chemiluminescent enzymatic immunoassay by
Specialty Laboratories, Inc. (Valencia, California) on the
DPC Immulite2000 analyzer (Siemens Medical Solutions
Diagnostics, Deerfield, Illinois). All samples were analyzed
at the Kaleida Center for Laboratory Medicine (Buffalo,
New York). All samples from a participant’s menstrual cy-
cle were analyzed together in 1 batch to control for inter-
assay differences. Across the study period, the interassay
coefficients of variation were reported as <10% for estra-
diol, <5% for LH and FSH, and <14% for progesterone.
Lipoprotein assessment
A complete lipid profile was performed for each cycle
visit, including analysis of total cholesterol, HDL choles-
terol, and triglycerides, measured using a Beckman LX20
automated chemistry analyzer at the Kaleida Center for
Laboratory Medicine (Buffalo, New York) (<5% coefficient
of variation). LDL cholesterol was determined indirectly
using the Friedewald formula (29).
Covariate assessment
Participants were asked to complete questionnaires on
lifestyle (smoking status), physical activity (International
Physical Activity Questionnaire long form 2002) (30), and
reproductive history. High, moderate, and low physical ac-
tivity categories were formed on the basis of standard In-
ternational Physical Activity Questionnaire cutpoints.
Physical and anthropometric measures were carried out ac-
cording to standardized protocols and included height and
weight, which were used to calculate BMI. All covariates
assessed had at least a 95% response rate.
Controlled direct effects
Figure 1 displays the direct effect of fiber on lipoprotein
cholesterol and the indirect effect of fiber on lipoprotein
cholesterol working through estradiol (31). This simplified
diagram could be extended to represent the longitudinal
structure of the data and the hypothesized confounders of
the fiber-lipoprotein (age, BMI, energy intake, and physical
activity), fiber-estradiol (age, BMI, energy intake, and vita-
min E intake) (12), and estradiol-lipoprotein (age, BMI, and
reproductive hormones) associations. We were interested in
estimating controlled direct effects, which are the direct
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effects observed when setting estradiol to a given level (e.g.,
45 pg/mL), which essentially controls for the effects of fiber
on estradiol. The proposed methods conceive of hypotheti-
cal interventions on the mediator (estradiol) that change its
value, so that controlled direct effects can be conceptualized
(with fixed values of the mediator). In theory, there are as
many direct effects as there are levels of estradiol, but in
practice, meaningful and realistically modifiable levels
should be used. We considered the controlled direct effects
where estradiol was set to the mean level among premeno-
pausal women on different formulations of oral contracep-
tives (30–110 pg/mL, equivalent to intervening and giving
women oral contraceptives), while accounting for the hy-
pothesized confounders (32–35). The levels of estradiol
considered in this analysis were all within the range of
values observed among the women in this study.
Statistical analysis
Descriptive statistics were computed for all study vari-
ables, and Fisher’s exact tests and repeated-measures anal-
ysis of variance were used to test for associations between
demographic variables and fiber intake by cycle, while tak-
ing multiple cycles per woman into account. Median hor-
mone levels across the cycle (estradiol, LH, FSH, and luteal
progesterone) and baseline (second day of menses during
the first menstrual cycle) lipoprotein cholesterol levels (total
cholesterol, HDL cholesterol, LDL cholesterol, and triglyc-
erides) were compared across levels of fiber intake, and P
values were calculated using repeated-measures analysis of
variance with Bonferroni-adjusted comparisons on the log-
transformed values (36). Hormone and lipoprotein values
were log-transformed for normality in statistical models.
Predicted mean levels of lipoproteins were calculated for
each visit by fiber intake after adjustment for age, BMI,
and total energy intake, using linear mixed models with
random intercepts (see Appendix).
The average daily fiber intake per cycle was calculated,
since there were no significant differences in dietary fiber
intake across phases of the cycle (12). Average fiber intake
per cycle was categorized into multiple groups of equal size
(e.g., 3 groups (tertiles), 4 groups (quartiles), 5 groups
(quintiles), and 8, 10 (deciles), 12, and 15 groups), and the
groups were compared using linear mixed models, adjusting
for age, BMI, and energy intake, as well as using linear
spline models, to determine whether there was evidence of
a threshold effect of fiber intake on lipoprotein cholesterol
levels.
Marginal structural models (MSMs) with inverse proba-
bility weights were applied to estimate total effects and
controlled direct effects of fiber intake on lipoprotein cho-
lesterol levels (37). Weighted generalized linear mixed-
effects models with random intercepts were used to estimate
the parameters of the MSM, allowing lipoprotein levels to
vary over time, and treating total fiber intake per cycle as
a dichotomous variable (22 g/day vs. <22 g/day). Intakes
of insoluble and soluble fiber above the 75th percentile were
also evaluated (11.4 g/day and 4.4 g/day, respectively). The
weighted generalized linear mixed-effects models utilize all
available data and do not rely on the complete case approach
for handling missing data. For estimation of total effects,
stabilized inverse probability weights for dichotomous fiber
intake per cycle were obtained by logistic regression (ad-
justing for total energy intake, age, BMI, and physical ac-
tivity) and applied to generalized linear mixed-effects
models. For estimation of controlled direct effects, weighted
generalized linear mixed-effects models were used to esti-
mate the counterfactual level of lipoprotein cholesterol (to-
tal cholesterol, LDL cholesterol, HDL cholesterol, and
triglycerides) at each time point modeled as a linear func-
tion of fiber intake, estradiol, and the interaction between
fiber and estradiol (see Appendix) (37).
Stabilized weights were obtained by estimating 2 sets of
weights, 1 for dichotomous fiber intake using logistic re-
gression and 1 for continuous estradiol levels by linear re-
gression, replacing the probabilities with values from
a normal probability density function (38). Weights were
calculated for fiber intake per cycle (2 total) and for estra-
diol at each cycle visit (16 total), and the weights were
multiplied together to form a single weight for each individ-
ual at each cycle visit. Models used to calculate the weights
included age, BMI, energy intake, vitamin E intake, physi-
cal activity, LH, FSH, and progesterone levels, as well as
past measurements of fiber and estradiol. Inverse probability
weighting is used to consistently estimate the parameters of
the MSM under the assumptions of positivity, no unmea-
sured confounding, and correct model specification (37–40).
To assess the impact of a possible unmeasured confound-
ing factor (high plasma volume) of the estradiol-cholesterol
relation on estimates of direct effects, we performed a sen-
sitivity analysis for direct effects (see Appendix) (41).
Plasma volume was considered as a potential unmeasured
confounder, since increases in total cholesterol during the
follicular phase could be due, at least in part, to the reduc-
tion in plasma volume observed during this phase of the
menstrual cycle (42–44). Hematocrit is a common measure
of plasma volume, but data on this factor were not collected
in this study. The sensitivity analysis estimated the differ-
ence in the prevalence of high plasma volume when
comparing high and low fiber intakes for various potential
effect sizes of the plasma volume–lipoprotein cholesterol
association.
Further, we evaluated the effects of meeting the Dietary
Reference Intake standard for fiber intake on lipoprotein
cholesterol levels, with the Dietary Reference Intake being
based on the Institute of Medicine’s recommendation of
14 g of fiber per day per 1,000 kcal (45). We calculated each
woman’s estimated fiber requirements on the basis of her
Figure 1. Direct and indirect effects of fiber intake on lipoprotein
cholesterol levels.
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% Mean (SD) Median (IQR)
No. of
Cycles
% Mean (SD) Median (IQR)
No. of
Cycles
% Mean (SD) Median (IQR)
No. of cyclesb 509 468 41
Demographic characteristics
Age, years 27.4 (8.2) 27.4 (8.3) 27.0 (8.0) 0.73
Body mass indexc 24.1 (3.9) 24.2 (3.8) 22.8 (4.3) 0.05
Race/ethnicity 0.04
White 302 59.3 269 57.5 33 80.5
Black 101 19.8 98 20.9 3 7.3
Other 106 20.8 101 21.6 5 12.2
High school education or less 65 12.8 63 13.5 2 4.9 0.29
Married 131 25.7 118 25.2 13 31.7 0.49
Nulliparous 367 73.6 336 73.4 31 75.6 0.81
Current smoker 20 3.9 20 4.3 0 0.0 0.98
Physical activity level 0.51
Low 48 9.5 44 9.4 4 9.8
Moderate 182 36.0 163 34.8 19 46.3
High 275 54.5 261 55.8 18 43.9
Past oral contraceptive use 275 54.7 248 53.7 27 65.9 0.24
Reproductive hormone levels
Estradiol, pg/mL 82.0 (10.0) 84.0 (108.0) 62.0 (75) 0.003
Luteal progesterone, ng/mL 7.0 (9.25) 7.2 (9.4) 4.8 (8.1) 0.04
Luteinizing hormone, ng/mL 5.7 (6.0) 5.7 (6.0) 5.6 (5.8) 0.21
Follicle-stimulating
hormone, mIU/mL
5.6 (4.0) 5.6 (4.1) 5.5 (3.6) 0.83
Baseline lipoprotein cholesterol
levels, mg/dL
Total cholesterol 160.0 (30.0) 160.5 (32.0) 147.0 (37.0) 0.01
High density lipoprotein
cholesterol
49.0 (17.0) 48.0 (17.0) 50.0 (16.0) 0.86
Low density lipoprotein
cholesterol
98.0 (29.0) 98.5 (29.0) 91.0 (35.0) 0.01
Triglycerides 53.0 (33.0) 53.0 (33.0) 49.0 (28.0) 0.08
Dietary intake
Total energy, kcal/day 1,608.1 (405.0) 1,578.7 (390.0) 1,943.3 (426.9) <0.01
Total fiber, g/day 13.6 (6.0) 12.3 (4.0) 28.1 (5.6) <0.0001





































estimated total energy intake from the 24-hour recall (e.g.,
for a woman consuming 1,500 kcal/day, her estimated re-
quirement would be 21 g/day) and her estimated energy
requirements according to her age, weight, height, and phys-
ical activity level, using the Institute of Medicine’s formula
for adult females (45). Fiber intake was categorized as at or
above the estimated requirement or below the estimated re-
quirement for each woman. SAS, version 9.1 (SAS Institute
Inc., Cary, North Carolina), was used for all statistical
analyses.
RESULTS
The women in the BioCycle Study were, on average, aged
27.3 years (range, 18–44) and consisted mainly of single,
nulliparous, normal-weight, highly physically active white
women with some postsecondary education. The average
fiber intake among the women in this study was 13.6 g/
day, with approximately 17% being derived from fruits,
36% from vegetables, and 41% from grains. Fiber intake
(22 g/day vs. <22 g/day) varied significantly according
to BMI and race/ethnicity, with heavier and minority
women tending to consume less fiber (Table 1). Average
estradiol level across the menstrual cycle, average luteal-
phase progesterone level, and baseline total cholesterol,
LDL cholesterol, and triglyceride levels were lower among
women consuming at least 22 g of fiber per day. Women
consuming fiber at levels of 22 g/day or more also had lower
predicted mean total cholesterol and LDL cholesterol levels
across the menstrual cycle after adjustment for age, BMI,
and total energy intake (Figure 2). Triglyceride levels were
lower during menses, during the follicular phase, and
around the time of expected ovulation. No consistent pattern
was observed for HDL cholesterol. The final sample used
for the analysis included all 259 women, and information
from missing visits comprised only 4.2% of the total obser-
vations (173 missing out of a possible 4,072).
Significant associations between high fiber intake and
total and LDL cholesterol levels were only observed when
the cutpoint for the highest category was above 21.8 g/day
or when knots for the spline models were greater than 20 g/
day, pointing to a possible threshold effect. In particular, the
highest fiber category was significantly different from all
categories of lower intake, with no differences in lipoprotein
cholesterol levels between the lower categories. Thus, fiber
intake was categorized according to whether a woman con-
sumed at least 22 g/day.
In models which estimated total effects, high total fiber
intake (22 g/day) and high soluble fiber intake (4.4 g/
day) were associated with decreased total and LDL choles-
terol levels, with no significant effects on HDL cholesterol
or triglycerides (Table 2). We observed significant con-
trolled direct effects of high fiber intakes on total and
LDL cholesterol levels. That is, high fiber intakes were
associated with lower total and LDL cholesterol levels,
not through estradiol, when LDL cholesterol was set to
levels of women on oral contraceptives (Table 3). The con-
trolled direct effects of high fiber consumption (22 g/day)
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approximately 7.5 mg/dL, on average, whereas the total
effects were associated with decreases of approximately
5.5 mg/dL, on average. Thus, total effects, which include
the mediating effects of estradiol, were smaller than the
direct effects that do not operate through estradiol. Con-
trolled direct effects on total cholesterol were also reduced
at higher estradiol levels (P for interaction ¼ 0.3) (direct
effects on triglyceride levels were also reduced (P for in-
teraction¼ 0.03)), whereas effects on LDL cholesterol were
consistent at each level of estradiol evaluated (P for inter-
action ¼ 0.9).
A sensitivity analysis showed that the controlled direct
effects we observed for total and LDL cholesterol are un-
likely to be explained by unmeasured confounding by
plasma volume of the estradiol-cholesterol association
(Table 4) (41). Even for a large change in total cholesterol
between persons with high and low plasma volumes (15-mg/
dL difference), the difference in prevalence of high plasma
volume between high and lower fiber intakes, conditional on
estradiol levels set at 30 pg/mL, would have to be 0.54 in
order to completely explain away the observed controlled
direct effect. A degree of confounding this extreme seems
implausible, and similar results were observed at other es-
tradiol levels and for LDL cholesterol.
We did not observe significant reductions in lipoprotein
cholesterol levels in response to meeting the estimated per-
centage requirements of fiber intake based on either a wom-
an’s estimated total energy intake from the 24-hour recall or
her estimated energy requirements according to her age,
weight, and height (data not shown). We observed a wide
range of energy intakes in this population (515–3,717 kcal),
corresponding to estimated fiber requirements of 7–52
g/day. Estimated energy requirements based on the Institute
of Medicine’s formula averaged 2,334 kcal/day, with a range
of 1,663–3,357 kcal/day, corresponding to estimated fiber
requirements of 23–47 g/day (45, 46).
DISCUSSION
We found that fiber consumption at or above 22 g/day was
associated with lower total cholesterol and LDL cholesterol
levels, independent of measured endogenous estradiol level,
when estradiol was set at levels corresponding to oral con-
traceptive use. The controlled direct effects of high fiber
intake were in fact larger than the total effects, since the
effect of fiber on cholesterol through estradiol has been
shown to increase cholesterol levels. The fact that direct
effects were larger than total effects suggests that estradiol
mediates the effect of fiber on lipoproteins; high-fiber diets
may also have reduced effects among premenopausal
women. The observed direct effects of fiber on total and
LDL cholesterol provide further insights regarding possible
biologic mechanisms of fiber on lipoprotein metabolism,
suggesting that fiber has a direct effect on lowering lipopro-
tein cholesterol levels, in addition to its effect that operates
through estradiol.
The observed associations between high fiber intake and
reduced total and LDL cholesterol levels are in line with
several randomized controlled trials and observational
studies that found fiber intake to be associated with a less
atherogenic lipid profile (11–19). In the randomized
controlled trials, women typically consumed more than
20 g/day of fiber. In observational studies, typically the
highest quintile of fiber intake was associated with lower
total cholesterol levels, with cutpoints similar to the thresh-
old we observed around 22 g/day (47). The apparent
threshold possibly could be explained by the low fiber
intakes in this population. However, we observed no
reductions in lipoprotein cholesterol levels for women just
meeting the estimated percentage requirements. Thus, it
seems that the direct effects of fiber intake on lowering
of lipoprotein cholesterol are due to high levels of intake
and not to consuming a certain percentage of fiber from the
diet.
The controlled direct effects of fiber on total cholesterol
were greater than the total effects and were slightly reduced
at high levels of estradiol. Our findings are similar to those
of studies comparing pre- and postmenopausal women that
have observed reduced responses to fiber supplementation
among premenopausal women (20, 21). In a study of 8 pre-
menopausal women and 11 postmenopausal women with
hypercholesterolemia, fiber supplementation (15 g/day) sig-
nificantly decreased total cholesterol levels from baseline
among postmenopausal women but not premenopausal
women (20). However, in a small crossover trial among
healthy persons, Vega-Lopez et al. (21) found that total
cholesterol decreased by 7% during the fiber supplementa-
tion period among men but only by 5% and 4% among pre-
and postmenopausal women, respectively. Interestingly,
they found that triglyceride levels increased among women
but decreased in men after fiber supplementation, highlight-
ing sex differences in response to fiber intake. While this
crossover trial differed from our study (i.e., a fiber supple-
mentation trial, an older and more obese study population,
and higher average fiber intakes before supplementation),
together these findings suggest potential differences in the
impact of fiber intake on lipoprotein cholesterol that could
be due to estradiol levels.
The decreased effect of fiber intake at high estradiol
levels and the magnitude of the total and direct effects
are also in line with biologic evidence. High fiber intake
has been associated with lower levels of estradiol (11–19),
presumably because of a reduction in b-glucuronidase ac-
tivity in feces in response to fiber intake, which subse-
quently leads to a decline in the reabsorption of estradiol
in the colon (47). Because increased intake of exogenous
estradiol tends to have beneficial effects on the lipid profile
in older women (48–50), the reduction in estradiol in
response to fiber intake would presumably lead to an in-
crease in lipoprotein cholesterol levels. In fact, we ob-
served that direct effects were larger in magnitude than
the total effects, suggesting that the direct effect of fiber
intake was opposite of the effect mediated through
estradiol.
To our knowledge, this is the first study to evaluate the
controlled direct effects of high fiber intake on lipoprotein
cholesterol levels. MSMs were used to estimate the con-
trolled direct effects because they offer several important
advantages over standard approaches. The most important
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advantages of this approach are that they can control for
time-varying confounders affected by prior exposure and
they can accommodate interactions between fiber and estra-
diol. First, MSMs adjust for time-modified confounding
caused by changing reproductive hormone levels during
the menstrual cycle. Second, based on our knowledge of
the effects of fiber on both estradiol and lipoproteins, the
absence of an interaction seems biologically implausible.
When such an interaction is present, the total effect cannot
be partitioned into direct and indirect effects using standard
approaches, and effect decomposition requires that addi-
tional assumptions be met when using MSMs (37, 51).
Had we analyzed the association using the standard
approach (comparing the effect estimate adjusted for poten-
tial confounders with an estimate adjusted for the same
confounders plus the hypothesized mediating variable)
(51–54), we would not have observed the varying effect of
fiber by estradiol level.
Our analysis was restricted by the assumptions of MSMs,
which limits the interpretation of our results (37–40). In
estimating controlled direct effects, we hypothesized inter-
ventions to set estradiol levels to a certain value. Although
intervention is possible through the use of oral contracep-
tives, it is not necessarily practical. In addition, MSMs are
based on several strong assumptions—specifically no un-
measured confounding, which is hard to verify but is as-
sumed in standard analysis methods as well (37–40).
Despite the fact that we had standardized assessments of
a wide variety of participant and dietary characteristics,
which increased our ability to adjust for potential con-
founders, unmeasured confounding is possible. However,
based on our sensitivity analysis, it is unlikely that these
results could be explained by unmeasured confounding. Ad-
justment for other dietary factors (i.e., total and saturated
















































































































Figure 2. Predicted mean levels of A) total cholesterol, B) low density lipoprotein (LDL) cholesterol, C) high density lipoprotein (HDL)
cholesterol, and D) triglycerides across the menstrual cycle according to fiber intake (squares, <22 g/day; circles, 22 g/day) among women
in the BioCycle Study, Buffalo, New York, 2005–2007. The predicted mean values were based on linear mixed-effects models with random
intercepts, adjusted for age, body mass index, and total energy intake, and correspond to total effects. (P values for the overall difference
between high and low fiber intakes across the menstrual cycle were 0.01 for total cholesterol, 0.005 for LDL cholesterol, 0.7 for HDL
cholesterol, and 0.5 for triglycerides).
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With regard to the assumption of positivity, given that
lipoprotein cholesterol levels and estradiol were considered
as continuous variables, practical violations could have
occurred. However, we observed a positive probability of
fiber intake at each level of the confounders when they
were categorized into meaningful categories. As a practical
assessment of positivity, we evaluated the distribution of
the weights to ensure that there were no extreme values,
and the mean was close to 1 (39). The distribution of the
weight models was not indicative of nonpositivity. We also
compared different model specifications for the weight
models, as well as the final MSM. The inferences did not
change on the basis of the model specification, and the
mean of the weights was very close to 1 (a necessary con-
dition for correct model specification (39)), thus supporting
this assumption. Although one might be interested in
estimating natural direct effects—direct effects where the
level of estradiol is allowed to vary—these effects are gen-
erally not identifiable when time-dependent confounding is
present (37).
Table 2. Estimated Total Effect of Fiber Intake on Log Lipoprotein
Levels (mg/dL) Among Women Participating in the BioCycle Study,






Total fiber intake 22 g/day
Model 1b 0.035 0.063, 0.007
Model 2c 0.036 0.063, 0.008
Insoluble fiber intake 11.4 g/day
Model 1 0.007 0.006, 0.020
Model 2 0.007 0.006, 0.019
Soluble fiber intake 4.4 g/day
Model 1 0.012 0.024, 0.0001
Model 2 0.012 0.024, 0.0001
High density lipoprotein cholesterol
Total fiber intake 22 g/day
Model 1 0.003 0.041, 0.034
Model 2 0.006 0.044, 0.031
Insoluble fiber intake 11.4 g/day
Model 1 0.002 0.015, 0.020
Model 2 0.002 0.015, 0.020
Soluble fiber intake 4.4 g/day
Model 1 0.001 0.018, 0.015
Model 2 0.003 0.190, 0.013
Low density lipoprotein cholesterol
Total fiber intake 22 g/day
Model 1 0.058 0.097, 0.018
Model 2 0.056 0.097, 0.019
Insoluble fiber intake 11.4 g/day
Model 1 0.004 0.015, 0.023
Model 2 0.004 0.015, 0.022
Soluble fiber intake 4.4 g/day
Model 1 0.021 0.038, 0.004
Model 2 0.020 0.037, 0.004
Triglycerides
Total fiber intake 22 g/day
Model 1 0.038 0.120, 0.044
Model 2 0.032 0.113, 0.050
Insoluble fiber intake 11.4 g/day
Model 1 0.053 0.014, 0.093
Model 2 0.053 0.014, 0.093
Soluble fiber intake 4.4 g/day
Model 1 0.010 0.027, 0.047
Model 2 0.010 0.027, 0.047
a The total effects presented here include both the direct effects (not medi-
ated through estradiol; Table 3) and the indirect effects (mediated through
estradiol).
b Results were adjusted for total energy intake.
c Results were adjusted for total energy intake, age, body mass index, phys-
ical activity, and menstrual cycle phase.
Table 3. Results From Marginal Structural Models for Estimating
the Controlled Direct Effect of Fiber Intake (22 g/day vs.<22 g/day)
on Log Lipoprotein Levels (mg/dL) Among Women Participating in












30 0.048 0.081, 0.014
45 0.045 0.076, 0.013





30 0.013 0.059, 0.032
45 0.012 0.056, 0.033





30 0.062 0.111, 0.015
45 0.062 0.111, 0.018
110 0.064 0.110, 0.020
Triglycerides 0.03
30 0.078 0.184, 0.027
45 0.053 0.151, 0.044
110 0.004 0.092, 0.099
a Estimates were adjusted for age, body mass index, physical
activity, total energy intake, vitamin E intake, luteinizing hormone,
follicle-stimulating hormone, and progesterone levels through the
use of inverse probability weights. Direct effects are the effects of fiber
on lipoprotein cholesterol levels that are not mediated through estra-
diol. The total effects shown in Table 2 include the mediating effects.
The direct effects shown here are larger than the total effects shown in
Table 2, suggesting that estradiol mediates at least part of the asso-
ciation.
b P value for the interaction between fiber and estradiol.
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We restricted our study sample to healthy, regularly men-
struating women in order to exclude potential confounders
by design, but such restrictions could also limit the gener-
alizability of our findings. While assessments of fiber intake
are subject to measurement error, our use of multiple vali-
dated 24-hour recalls reduced the potential for a large de-
gree of misclassification (25–27). Differences in weekday
versus weekend consumption are not likely to have been
a significant source of misclassification. While the average
fiber intake among women in this study was 13.6 g/day
(standard deviation, 6.0), which is substantially lower than
the current recommendations, this level of intake is compa-
rable to the average fiber intake in the United States (13.8
g/day for reproductive-age women). We were also limited
by observing only a small number of women consuming at
least 22 g/day. While fiber intakes were low, there was no
evidence of a drop-off of intakes across the cycle, and to our
knowledge the women were not engaged in strenuous phys-
ical training. We were unable to directly address other pos-
sible pathways, since we did not have information on bile
acid levels or other potential mechanisms.
In conclusion, we observed reductions in total cholesterol
and LDL cholesterol that were not mediated through estra-
diol among women consuming at least 22 g/day of fiber,
when setting estradiol at specified levels corresponding to
oral contraceptive use. The lipid-lowering effects of fiber
intake were observed only at high levels, indicating the
importance of consuming a high amount of fiber. The con-
trolled direct effects of fiber intake were greater than the
total effects, suggesting that estradiol may mediate the as-
sociation between fiber and lipoproteins by slightly dimin-
ishing the effect. These results support recommendations of
a high-fiber diet, however, with reduced effects to be ex-
pected among premenopausal women due to higher estra-
diol levels. These findings regarding direct effects provide
further insight into possible biologic mechanisms and sup-
port the hypothesis of a direct effect that might work
through alternative pathways such as bile acid metabolism.
More research is needed to elucidate these mechanisms
among premenopausal women.
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1 7.70c 7.22 6.26 6.23 6.33 6.53
5 1.56 1.46 1.27 1.27 1.29 1.33
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effects of high plasma volume on lipoprotein cholesterol, there is no prevalence difference that
would eliminate the observed effects.
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APPENDIX
Model Specification and Sensitivity Analysis for Direct
Effects
Model specification
Predicted mean levels of lipoproteins were calculated for
each visit by fiber intake after adjustment for age, body mass
index, and total energy intake, using linear mixed models
with random intercepts. An example of the linear mixed
model is given in equation 1, where i indexes patient (1,
. . ., n), j represents cycle (1, 2), k represents visit (1, . . .,
8), Y refers to the lipid parameter of interest, A refers to
dichotomous fiber intake per cycle, C represents the con-
founding factors age, body mass index, and total energy
intake, and ‘‘Visit’’ represents cycle phase.
Yijk ¼ Aijb1 þ Cijb2 þ Visitijkb3k þ bi þ eijk: ð1Þ
For estimation of controlled direct effects, weighted gen-
eralized linear mixed-effects models were used to estimate
the counterfactual level of lipoprotein cholesterol (total cho-
lesterol, low density lipoprotein cholesterol, high density
lipoprotein cholesterol, and triglycerides) at each time point
modeled as a linear function of fiber intake (A), estradiol
(M), and the interaction between fiber and estradiol (A3M)
(37). The linear mixed-effects model shown in equation 2
was used to estimate the parameters of the marginal struc-
tural model, where C includes the baseline covariates used
for stabilization of the weights. The model is weighted by
wijk, with stabilized weights obtained by estimating 2 sets of
weights, one for fiber intake and one for estradiol levels.
Yijk ¼ Aijb1 þMijkb2 þ Aij 3Mijkb3 þ Cijb4
þ Visitijkb4k þ bi þ eijk:
ð2Þ
Sensitivity analysis
Weadapt results for sensitivity analysis for direct effects with
1 measurement for each variable (41) to the time-varying
setting we are considering here. Let Yt denote serum lipid
cholesterol level at time t, letMt denote estradiol level at time
t, and letAt denote a high-fiber diet versus a low-fiber diet. Let
Lt denote the measured covariates at time t. Note that in this
studyAt is assumed to befixedover time (thoughLt,Mt, andYt
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vary). Finally, letUt denote an unmeasured binary confound-
ing variable such as plasma volume levels (high vs. low),
which we hypothesize affects both estradiol levels Mt and
cholesterol levels Yt but does not affect high fiber intake
versus low fiber intake At.
The repeated-measures marginal structural model as-
sumed that current cholesterol Yt depended on fiber intake
but only on the most recent estradiol levels (rather than the
entire history). Suppose now also that current cholesterol Yt
depends only on recent plasma levels (rather than the entire
history). Let Yt(a,m) denote the counterfactual cholesterol
level at time t if fiber had been set to level a and recent
estradiol to level m. The marginal structural model is
a model for Yt(a,m). Suppose that the effects of A and M
on Ywere unconfounded conditional on (Lt ,Ut) but not on Lt
alone. We are then interested in the difference between what
would be estimated as the controlled direct effect (with the
mediator fixed at level m) if adjustment were made for (Lt,
Ut) versus adjustment for just Lt. Under the above assump-
tions, along with the assumption that the unmeasured con-
founder Ut does not interact on the additive scale with A in
its effects on cholesterol, this difference reduces to cd,
where c denotes the effect of high versus low plasma levels
on cholesterol on the additive scale and d denotes the dif-
ference in the prevalence of U comparing high fiber (A ¼ 1)
with low fiber (A ¼ 0), conditional on estradiol being set to
level m; by assuming that current cholesterol depends only
on the most recent levels of estradiol and plasma, the sen-
sitivity analysis for the time-varying settings reduces to that
in which there is a single time period for each variable.
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